Company / Revenue per Share
Caris Life Sciences, Inc. Revenue per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$22.24
FY2025
5-year range
$8.76 / $22.24
FY2023-FY2025
Trend
+91.5%
vs FY2024
Sector context
#78 of 154
Health Care
What the data says
At $22.24, Caris Life Sciences, Inc.'s revenue per share ranks #78 of 154 in the Health Care sector. Improved from $8.76 to $22.24 over the past 2 years.
Based on SEC 10-K filings.
22.24 in FY2025.
Improved from $8.76 to $22.24 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#78 of 154 in Health CareTop 51% of 154This company $22.24 Sector average $123.99
▼
-82.1% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 91.5% year-over-year.
- Ranks #78 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.24 | +91.5% |
| FY2024 | $11.61 | +32.6% |
| FY2023 | $8.76 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026